← Leaderboards
Josef T Prchal
University Of Alabama At Birmingham
$8,723,783
Attributed
$9,786,309
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $703.2K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,786,309 · 8
VA$0 · 3
By mechanism
R01$3,085,572 · 2
T32$3,043,638 · 2
P01$1,960,339 · 2
P60$1,696,760 · 2
I01$0 · 3
Top collaborators
- Elizabeth Ann Leibold8 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Peter D Emanuel$39,860,242
- Elizabeth Ann Eklund$14,527,585
Others in their field
Top investigators on “Erythropoietin”
- Sandra E Juul · University Of Florida$25,024,901
- Merav Socolovsky · Whitehead Institute For Biomedical Res$12,580,255
- Harvey Jay Cohen · Duke University$12,110,424
- Samuel J Danishefsky · Sloan-Kettering Institute For Cancer Res$10,626,893
- Isidro B. Benjamin Salusky · University Of California Los Angeles$9,929,420
- Harvey F Lodish · Children'S Hospital Boston$9,871,966
Research focus
ErythropoietinClinical ResearchPolycythemiaHypoxiaMolecularCellsGene ExpressionGenesErythroidErythropoiesisMessenger RnaProgenitorFamily GeneticsHuman SubjectMutationTissue /Cell CulturePlayErythrocytesBloodPhenotypeTranscriptHypoxia Inducible Factor 1RegulationTranscription Factor
Grant awards (45)
Mechanism of thrombosis in two myeloproliferative neoplasms (MPNs), polycythemia vera and essential thrombocythemia$0
I01 · FY2024 · VA · contact PI
Mechanism of thrombosis in two myeloproliferative neoplasms (MPNs), polycythemia vera and essential thrombocythemia$0
I01 · FY2023 · VA · contact PI
HIF-Mediated Detrimental Consequences of Chronic Intermittent Hypoxia$0
I01 · FY2021 · VA · contact PI
Research Training in Hematology$362,457
T32 · FY2020 · DK
Research Training in Hematology$38,267
T32 · FY2020 · DK
HIF-Mediated Detrimental Consequences of Chronic Intermittent Hypoxia$0
I01 · FY2020 · VA · contact PI
Research Training in Hematology$329,607
T32 · FY2019 · DK
Research Training in Hematology$48,417
T32 · FY2019 · DK
HIF-Mediated Detrimental Consequences of Chronic Intermittent Hypoxia$0
I01 · FY2019 · VA · contact PI
Research Training in Hematology$311,372
T32 · FY2018 · DK
HIF-Mediated Detrimental Consequences of Chronic Intermittent Hypoxia$0
I01 · FY2018 · VA · contact PI
Research Training in Hematology$290,839
T32 · FY2017 · DK
HIF-Mediated Detrimental Consequences of Chronic Intermittent Hypoxia$0
I01 · FY2017 · VA · contact PI
Research Training in Hematology$230,607
T32 · FY2016 · DK
Research Training in Hematology$513,486
T32 · FY2014 · DK
Erythropoietin in Non-Erythroid Cells: Function and Regulation$0
I01 · FY2013 · VA · contact PI
Erythropoietin in Non-Erythroid Cells: Function and Regulation$0
I01 · FY2012 · VA · contact PI
Genetic Basis of Polycythemia Vera$463,212
P01 · FY2011 · CA · contact PI
Erythropoietin in Non-Erythroid Cells: Function and Regulation$0
I01 · FY2011 · VA · contact PI
Genetic Basis of Polycythemia Vera$430,178
P01 · FY2009 · CA · contact PI
Erythropoietin in Non-Erythroid Cells: Function and Regulation$0
I01 · FY2009 · VA · contact PI
Genetic Basis of Polycythemia Vera$428,875
P01 · FY2008 · CA · contact PI
Molecular Biology of Polycythemia$354,382
R01 · FY2007 · HL · contact PI
Genetic Basis of Polycythemia Vera$348,771
P01 · FY2007 · CA · contact PI
Molecular Biology of Polycythemia$364,967
R01 · FY2006 · HL · contact PI
Genetic Basis of Polycythemia Vera$289,303
P01 · FY2006 · CA · contact PI
Molecular Biology of Polycythemia$341,395
R01 · FY2005 · HL
Hematology Training Grant$385,052
T32 · FY2004 · DK
Molecular Biology of Polycythemia$348,395
R01 · FY2004 · HL
Hematology Training Grant$305,843
T32 · FY2003 · DK
HYPOXIA SENSING IN CHUVASH POLYCYTHEMIA$261,625
R01 · FY2003 · HL
HYPOXIA SENSING IN CHUVASH POLYCYTHEMIA$261,625
R01 · FY2002 · HL
STEM CELL KINETICS AND GENETIC THERAPIES FOR SICKLE CELL DISEASE$228,564
P60 · FY2002 · HL
STEM CELL KINETICS AND GENETIC THERAPIES FOR SICKLE CELL DISEASE$228,564
P60 · FY2002 · HL
CORE--DIAGNOSTIC LABORATORY$228,564
P60 · FY2002 · HL
CORE--DIAGNOSTIC LABORATORY$228,564
P60 · FY2002 · HL
Hematology Training Grant$227,691
T32 · FY2002 · DK
MOLECULAR BIOLOGY OF PRIMARY POLYCYTHEMIA$319,461
R01 · FY2001 · HL
HYPOXIA SENSING IN CHUVASH POLYCYTHEMIA$261,625
R01 · FY2001 · HL
CORE--DIAGNOSTIC LABORATORY$228,564
P60 · FY2001 · HL
STEM CELL KINETICS AND GENETIC THERAPIES FOR SICKLE CELL DISEASE$228,564
P60 · FY2001 · HL
MOLECULAR BIOLOGY OF PRIMARY POLYCYTHEMIA$310,472
R01 · FY2000 · HL
HYPOXIA SENSING IN CHUVASH POLYCYTHEMIA$261,625
R01 · FY2000 · HL
CORE--DIAGNOSTIC LABORATORY$162,688
P60 · FY2000 · HL
STEM CELL KINETICS AND GENETIC THERAPIES FOR SICKLE CELL DISEASE$162,688
P60 · FY2000 · HL